This trial will test a new drug to see if it is safe and effective in treating people who have had a kidney transplant and whose disease has returned.
2 Primary · 11 Secondary · Reporting Duration: 12 weeks after randomization
Experimental Treatment
12 Total Participants · 1 Treatment Group
Primary Treatment: Pegcetacoplan · No Placebo Group · Phase 2
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: